Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Newsworthy Abstract
Registration Required
No CME
On-Demand Video
Livestream
Back
Favorite
Post (Tweet)
Darren Wheeler, PhD
Intercept Pharmaceuticals, Inc.
Poster(s):
P1754 - Effect of Obeticholic Acid on Reduction and Normalization of Alanine Aminotransferase and Aspartate Aminotransferase in the Phase 3 POISE Trial in Primary Biliary Cholangitis
Monday, October 28, 2024
10:30 AM – 4:00 PM
ET
P1755 - Association of Elevated Liver Biochemistries and Clinical Outcomes Within Strata of Alkaline Phosphatase Levels in Patients With Primary Biliary Cholangitis
Monday, October 28, 2024
10:30 AM – 4:00 PM
ET
P3491 - Evaluation of Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index Stabilization in the Phase 3 POISE Trial of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis
Tuesday, October 29, 2024
10:30 AM – 4:00 PM
ET
P3492 - Stabilization of Enhanced Liver Fibrosis and Liver Stiffness Measures in the Open-Label Extension of the Phase 3 POISE Trial of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis
Tuesday, October 29, 2024
10:30 AM – 4:00 PM
ET
